Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928992 · ClinicalTrials.gov registry record
Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection in 3D Versus 2D Digital Mammography
A clinical trial, sponsored by Fujifilm Medical Systems USA.
- Completed
- Registry status
- 100
- Enrollment target
NCT01928992: Completed study, sponsored by Fujifilm Medical Systems USA.
NCT01928992 is a clinical trial that has completed, run by Fujifilm Medical Systems USA. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01928992 has completed, sponsored by Fujifilm Medical Systems USA.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to provide credible performance estimate information in order to properly plan, design, and power a larger clinical study.
Primary Outcome
Breast AUC performance metrics to determine if 3D has improved breast cancer detection rate as compared to 2D.
Interventions
- DEVICE 3D
- DEVICE 2D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-03 |
| Est. Completion | 2013-06 |
What the finished NCT01928992 record still lists
NCT01928992 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which 3D is the first listed.
NCT01928992 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01928992 about?
NCT01928992 is a clinical study titled "Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection in 3D Versus 2D Digital Mammography". The purpose of this pilot study is to provide credible performance estimate information in order to properly plan, design, and power a larger clinical study.
What is the current status of trial NCT01928992?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01928992?
The interventions under investigation include: 3D (DEVICE), 2D (DEVICE).
Who is sponsoring clinical trial NCT01928992?
This trial is sponsored by Fujifilm Medical Systems USA, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia